Nobody is going to point out that of the 11 patients, "8 had significant comorbidities associated with poor outcomes (obesity: 2; solid cancer: 3; hematological cancer: 2; HIV-infection: 1)"?

I don't even understand what the point of this study was except as a rebuttal to the prior study. I mean, if people thought the prior study was cherry picking results. I don't even know what I'd call this...

There's _some_ anecdotal evidence that it _may_ work if treated early. Hopefully there are some real studies that are being done on that.